N-(4-cyanophenyl){4-[7-(2-morpholin-4-ylethoxy)quinazolin-4-yl]piperazinyl}carboxamide | 401572-08-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: N-(4-cyanophenyl){4-[7-(2-morpholin-4-ylethoxy)quinazolin-4-yl]piperazinyl}carboxamide
• 英文别名: N-(4-cyanophenyl)-4-[7-(2-morpholin-4-ylethoxy)quinazolin-4-yl]piperazine-1-carboxamide
• CAS: 401572-08-5
• 化学式: C₂₆H₂₉N₇O₃
• 分子量: 487.561
• InChiKey: OFYUAIKSDFKVJY-UHFFFAOYSA-N

物化性质

• 沸点：
  777.7±60.0 °C(Predicted)
• 密度：
  1.37±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  36
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  107
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• Nitrogenous heterocylic compounds
  申请人：——

  公开号：US20040186110A1

  公开（公告）日：2004-09-23

  The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

  本发明涉及含氮杂环化合物及其药学上可接受的盐，具有对激酶磷酸化的抑制活性，从而抑制了这些激酶的活性。本发明还涉及一种通过抑制激酶的磷酸化来抑制激酶并治疗哺乳动物疾病状态的方法。在特定方面，本发明提供了含氮杂环化合物及其药学上可接受的盐，抑制PDGF受体的磷酸化，以阻止异常细胞生长和细胞游走，并预防或治疗细胞增殖性疾病，如动脉硬化、血管再狭窄、癌症和肾小球硬化。
• Nitrogenous heterocyclic compounds
  申请人：Pandey Anjali

  公开号：US20060063770A1

  公开（公告）日：2006-03-23

  The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

  本发明涉及一种含氮杂环化合物及其药学上可接受的盐，具有对激酶磷酸化的抑制活性，从而抑制这些激酶的活性。该发明还涉及通过抑制激酶的磷酸化来抑制激酶并治疗哺乳动物的疾病状态的方法。在特定方面，本发明提供了一种含氮杂环化合物及其药学上可接受的盐，其抑制PDGF受体的磷酸化，以阻碍异常细胞生长和细胞游走，并用于预防或治疗细胞增殖性疾病，如动脉粥样硬化、血管再狭窄、癌症和肾小球硬化。
• US6956039B2
  申请人：——

  公开号：US6956039B2

  公开（公告）日：2005-10-18